Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation

David B Beck,Mohammed A Basar,Anthony J Asmar,Joyce J Thompson,Hirotsugu Oda,Daniela T Uehara,Ken Saida,Sander Pajusalu,Inga Talvik,Precilla D'Souza,Joann Bodurtha,Weiyi Mu,Kristin W Barañano,Noriko Miyake,Raymond Wang,Marlies Kempers,Tomoko Tamada,Yutaka Nishimura,Satoshi Okada,Tomoki Kosho,Ryan Dale,Apratim Mitra,Ellen Macnamara,Undiagnosed Diseases Network,Naomichi Matsumoto,Johji Inazawa,Magdalena Walkiewicz,Katrin Õunap,Cynthia J Tifft,Ivona Aksentijevich,Daniel L Kastner,Pedro P Rocha,Achim Werner
DOI: https://doi.org/10.1126/sciadv.abe2116
2021-01-20
Abstract:Reversible modification of proteins with linkage-specific ubiquitin chains is critical for intracellular signaling. Information on physiological roles and underlying mechanisms of particular ubiquitin linkages during human development are limited. Here, relying on genomic constraint scores, we identify 10 patients with multiple congenital anomalies caused by hemizygous variants in OTUD5, encoding a K48/K63 linkage-specific deubiquitylase. By studying these mutations, we find that OTUD5 controls neuroectodermal differentiation through cleaving K48-linked ubiquitin chains to counteract degradation of select chromatin regulators (e.g., ARID1A/B, histone deacetylase 2, and HCF1), mutations of which underlie diseases that exhibit phenotypic overlap with OTUD5 patients. Loss of OTUD5 during differentiation leads to less accessible chromatin at neuroectodermal enhancers and aberrant gene expression. Our study describes a previously unidentified disorder we name LINKED (LINKage-specific deubiquitylation deficiency-induced Embryonic Defects) syndrome and reveals linkage-specific ubiquitin cleavage from chromatin remodelers as an essential signaling mode that coordinates chromatin remodeling during embryogenesis.
What problem does this paper attempt to address?